The Effect of Intravenous Taxane-Related Toxicities on Metastatic Breast Cancer Disease Treatment and Healthcare Costs

This publication was supported by Athenex Oncology.

This AJMC^® Clinical Brief explores the effect that taxane-related toxicities have on the treatment of metastatic breast cancer and healthcare costs, including the economic and clinical burdens. This publication also includes thought leader perspectives from the Medical Director of Managed Care at OneOncology, John Fox, MD, MHA.

Download PDF